- ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology
- Updated the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.
Toronto, Ontario–(March 9, 2021) – Universal PropTech Inc. (TSXV:UPI) (FSE:8LH) (“UPI” or the “Company“) is pleased to announced that ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology including updating the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.
ISBRG’s SpotLight-19© technology leverages advancements in optics and artificial intelligence to define a state of COVID-19 infection.
SpotLight-19© (which upon testing to establish specificity and sensitivity ISBRG intends to submit for regulatory approval) is designed to screen for a unique infectious state – within 20 seconds of scanning a fingertip with light. ISBRG is undertaking trials to determine SpotLight-19©’s efficacy in detecting COVID-19, and if proven effective, will be subject to further regulatory approvals before it would be commercially available.
The speed and estimated cost of the test (approximately one dollar), combined with the non-invasive nature of light (no body fluid of any kind is required), is intended to accommodate the testing of large numbers of people without the inconvenient delays and environmental damage associated with current chemical reagent-based tests.
Below is an image of a finger over the beam of light from ISBRG Corp’s SpotLight-19 device.
ISBRG Corp’s SpotLight-19 device
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5341/76555_e6bb61ceb4a639fe_002full.jpg
“We are very excited that ISBRG has begun to inform the world of the high expectations for SpotLight-19,” commented Chris Hazelton, President and CEO of UPI. “Pending further testing and submission for regulatory approval, a 20-second COVID-19 test will open the global economy, and at an approximate cost of $1 per test, will enable governments around the world to afford and adopt rapid testing for COVID-19. We look forward to the results of ISBRG’s clinical trials and we have high hopes for its success. Once shown to be effective in testing for COVID-19, we expect other applications to follow.”
The global COVID-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].
In addition, the ISBRG website adds that ISBRG’s technology is designed for other applications, including for viral infection – screening technology to detect unique infections, including COVID-19; drug impairment – defining a unique state of impairment (such as THC); athletic fitness – defining a state of optimal fitness performance; nutritional health – defining the impact of dietary and / or supplement choices; healthy aging – defining the impact of gradual lifestyle changes and aging; and adolescent health – defining the impact of early stage lifestyle, exercise and nutrition decisions.
Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/756884-universal-proptech-inc-provides-update-on-spotlight-19c-designed-to-detect-covid-19-in-under-20-seconds-and-at-a-cost-of-approximately-1-per-test/messages/2307213#message
Tags: AI, Big data, Cloud Computing, Delta-X Global Corp., investing, IOT, PropTech